
Mangoceuticals, Inc.
MGRXNasdaqCIK 1938046HealthcareFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-12-1116:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-044387 |
| 2023-11-0716:15 ET | 8-K | 3.01 Delisting notice | 0001493152-23-039745 |
| 2023-11-0116:15 ET | 8-K | 3.01 Delisting notice | 0001493152-23-038998 |
| 2023-10-2716:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-038526 |
| 2023-10-1909:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-037680 |
| 2023-10-0416:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-035673 |
| 2023-09-2116:39 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-033356 |
| 2023-09-0816:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-032100 |
| 2023-07-2816:15 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-025879 |
| 2023-06-2316:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-23-022269 |
| 2023-05-1018:26 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016003 |
| 2023-05-0409:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-015389 |
| 2023-05-0320:55 ET | SC 13D | Ownership report, active investor | 0001493152-23-015231 |
| 2023-02-2808:45 ET | S-1/A | Registration statement, amended | 0001493152-23-006152 |
| 2023-02-2115:17 ET | S-1/A | Registration statement, amended | 0001493152-23-005634 |
| 2023-02-0618:53 ET | S-1/A | Registration statement, amended | 0001493152-23-003585 |
| 2023-01-2616:53 ET | S-1/A | Registration statement, amended | 0001493152-23-002627 |
| 2023-01-1317:28 ET | S-1 | Registration statement | 0001493152-23-001478 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:08 ET. Listed shows no prices and gives no investment advice.